journal article·2023-09Open access

Oligomer Dynamics of LL‐37 Truncated Fragments Probed by α‐Hemolysin Pore and Molecular Simulations

Chang Liu, Anja Henning‐Knechtel, Nicklas Österlund, Jinming Wu, Guangshun Wang, Ruth Astrid Olivia Gräslund, Serdal Kirmizialtin, Jinghui Luo

Small· Volume 19· Issue 37

Abstract

Abstract Oligomerization of antimicrobial peptides (AMPs) is critical in their effects on pathogens. LL‐37 and its truncated fragments are widely investigated regarding their structures, antimicrobial activities, and application, such as developing new antibiotics. Due to the small size and weak intermolecular interactions of LL‐37 fragments, it is still elusive to establish the relationship between oligomeric states and antimicrobial activities. Here, an α‐hemolysin nanopore, mass spectrometry (MS), and molecular dynamic (MD) simulations are used to characterize the oligomeric states of two LL‐37 fragments. Nanopore studies provide evidence of trapping events related to the oligomer formation and provide further details on their stabilities, which are confirmed by MS and MD simulations. Furthermore, simulation results reveal the molecular basis of oligomer dynamics and states of LL‐37 fragments. This work provides unique insights into the relationship between the oligomer dynamics of AMPs and their antimicrobial activities at the single‐molecule level. The study demonstrates how integrating methods allows deciphering single molecule level understanding from nanopore sensing approaches.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanopore and Nanochannel Transport Studies · Antimicrobial Peptides and Activities · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biology and Chemistry Paul Scherrer Institute Villigen 5232 Switzerland

Science Division New York University Abu Dhabi Saadiyat Island Abu Dhabi 129188 UAE

Department of Biochemistry and Biophysics Stockholm University Stockholm 106 91 Sweden

Department of Pathology and Microbiology, University of Nebraska Medical Center 985900 Nebraska Medical Center Omaha NE 68198‐5900 USA

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung · China Scholarship Council

References (52)

Show source-provided references
1. 10.1093/nar/gkv127810.1093/nar/gkv1278 ↗
2. 10.1016/j.it.2008.12.00310.1016/j.it.2008.12.003 ↗
3. 10.1002/bip.1026010.1002/bip.10260 ↗
4. 10.1016/j.bpj.2013.11.448610.1016/j.bpj.2013.11.4486 ↗
5. 10.1111/j.1574-695X.2010.00710.x10.1111/j.1574-695X.2010.00710.x ↗
6. 10.1002/anie.20221648010.1002/anie.202216480 ↗
7. 10.1016/j.bbamem.2013.02.01110.1016/j.bbamem.2013.02.011 ↗
8. 10.1016/j.cellimm.2012.11.00910.1016/j.cellimm.2012.11.009 ↗
9. 10.1128/IAI.63.4.1291-1297.199510.1128/IAI.63.4.1291-1297.1995 ↗
10. 10.1016/j.bbamem.2014.01.01610.1016/j.bbamem.2014.01.016 ↗
11. 10.1074/jbc.M80553320010.1074/jbc.M805533200 ↗
12. 10.1042/bj341050110.1042/bj3410501 ↗
13. 10.1016/j.pep.2007.02.00310.1016/j.pep.2007.02.003 ↗
14. 10.1042/BJ2013104810.1042/BJ20131048 ↗
15. 10.3389/fmicb.2020.0016810.3389/fmicb.2020.00168 ↗
16. 10.1038/s41598-020-74401-510.1038/s41598-020-74401-5 ↗
17. 10.1126/science.274.5294.185910.1126/science.274.5294.1859 ↗
18. 10.1038/nnano.2009.1210.1038/nnano.2009.12 ↗
19. 10.1039/D0NR08729G10.1039/D0NR08729G ↗
20. 10.1021/jacs.5b0791010.1021/jacs.5b07910 ↗
21. 10.1038/s41467-017-01588-z10.1038/s41467-017-01588-z ↗
22. 10.1021/ac102987410.1021/ac1029874 ↗
23. 10.1021/ac401496x10.1021/ac401496x ↗
24. 10.1021/acsami.6b0369710.1021/acsami.6b03697 ↗
25. 10.1038/s41467-019-08761-610.1038/s41467-019-08761-6 ↗
26. 10.1038/s41467-019-12690-910.1038/s41467-019-12690-9 ↗
27. 10.1021/jp071364h10.1021/jp071364h ↗
28. 10.1002/pssb.20066681210.1002/pssb.200666812 ↗
29. 10.1038/s41598-019-42867-710.1038/s41598-019-42867-7 ↗
30. 10.1002/smll.20190003610.1002/smll.201900036 ↗
31. 10.1038/s41467-020-17736-x10.1038/s41467-020-17736-x ↗
32. 10.1016/j.bbamem.2015.11.00310.1016/j.bbamem.2015.11.003 ↗
33. 10.1021/bi026048210.1021/bi0260482 ↗
34. 10.1074/jbc.M50704220010.1074/jbc.M507042200 ↗
35. 10.1111/j.1742-4658.2008.06536.x10.1111/j.1742-4658.2008.06536.x ↗
36. 10.1021/bi900272r10.1021/bi900272r ↗
37. 10.1016/j.bmcl.2013.12.02310.1016/j.bmcl.2013.12.023 ↗
38. 10.1007/s00018-022-04440-w10.1007/s00018-022-04440-w ↗
39. 10.1042/BJ2004213810.1042/BJ20042138 ↗
40. 10.1111/j.1399-3011.1998.tb01361.x10.1111/j.1399-3011.1998.tb01361.x ↗
41. 10.1002/anie.20210449710.1002/anie.202104497 ↗
42. 10.1016/j.xcrp.2022.10124310.1016/j.xcrp.2022.101243 ↗
43. 10.1016/j.xcrp.2022.10102810.1016/j.xcrp.2022.101028 ↗
44. 10.1038/nmeth.406710.1038/nmeth.4067 ↗
45. 10.1063/1.44586910.1063/1.445869 ↗
46. 10.1063/1.46439710.1063/1.464397 ↗
47. 10.1002/jcc.54013080510.1002/jcc.540130805 ↗
48. 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H ↗
49. 10.1063/1.32869310.1063/1.328693 ↗
50. 10.1063/1.44811810.1063/1.448118 ↗
51. 10.1021/acs.jctc.1c0064510.1021/acs.jctc.1c00645 ↗
52. 10.1002/prot.2003310.1002/prot.20033 ↗